Gorman Kevin Charles insider trades
Gorman Kevin Charles has filed 31 Form 4s with the SEC that we hold, for Neurocrine Biosciences INC (NBIX) (Director) and Xencor Inc (XNCR) (Director). Across all of them we count 1 purchase worth $1.0K and 27 sales worth $104.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($37.9M). The largest single trade was a sale of 245,088 shares of Neurocrine Biosciences INC worth $37.8M, dated 2026-05-19. The first filing on our record is dated 2022-02-02 and the latest 2026-09-15.
Neurocrine Biosciences INC (NBIX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-07 | S, sale reported on Form 4 | 3,040 | $245.6K | 2022-02-09 |
| 2022-02-07 | S, sale reported on Form 4 | 3,248 | $262.5K | 2022-02-09 |
| 2022-02-07 | S, sale reported on Form 4 | 2,422 | $195.8K | 2022-02-09 |
| 2022-02-08 | S, sale reported on Form 4 | 2,274 | $180.8K | 2022-02-09 |
| 2023-01-31 | S, sale reported on Form 4 | 2,707 | $298.0K | 2023-02-02 |
| 2023-02-06 | S, sale reported on Form 4 | 3,040 | $321.3K | 2023-02-08 |
| 2023-02-07 | S, sale reported on Form 4 | 20,482 | $2.1M | 2023-02-08 |
| 2023-02-07 | S, sale reported on Form 4 | 3,248 | $332.3K | 2023-02-08 |
| 2023-02-08 | S, sale reported on Form 4 | 2,274 | $237.2K | 2023-02-08 |
| 2023-08-21 | S, sale reported on Form 4 | 9,328 | $1.0M | 2023-08-23 |
| 2024-01-08 | S, sale reported on Form 4 | 105,835 | $14.0M | 2024-01-10 |
| 2024-01-09 | S, sale reported on Form 4 | 62,023 | $8.3M | 2024-01-10 |
| 2024-01-31 | S, sale reported on Form 4 | 2,707 | $380.8K | 2024-02-02 |
| 2024-02-06 | S, sale reported on Form 4 | 3,040 | $432.2K | 2024-02-08 |
| 2024-02-08 | S, sale reported on Form 4 | 2,274 | $305.1K | 2024-02-08 |
| 2024-02-13 | S, sale reported on Form 4 | 2,832 | $376.7K | 2024-02-15 |
| 2025-01-27 | S, sale reported on Form 4 | 146,105 | $21.8M | 2025-01-29 |
| 2025-01-31 | S, sale reported on Form 4 | 2,707 | $414.0K | 2025-02-04 |
| 2025-02-10 | S, sale reported on Form 4 | 2,274 | $269.2K | 2025-02-12 |
| 2025-02-13 | S, sale reported on Form 4 | 2,832 | $330.5K | 2025-02-14 |
| 2025-02-13 | S, sale reported on Form 4 | 3,012 | $351.4K | 2025-02-14 |
| 2025-05-27 | S, sale reported on Form 4 | 9,613 | $1.2M | 2025-05-29 |
| 2025-08-07 | S, sale reported on Form 4 | 106,322 | $13.4M | 2025-08-11 |
| 2026-05-19 | S, sale reported on Form 4 | 245,088 | $37.8M | 2026-05-21 |
Xencor Inc (XNCR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-02-13 | P, purchase reported on Form 4 | 53 | $1.0K | 2024-02-15 |
| 2024-09-27 | S, sale reported on Form 4 | 2,654 | $54.9K | 2024-10-01 |
| 2025-06-16 | S, sale reported on Form 4 | 3,173 | $29.3K | 2025-06-16 |
| 2026-06-15 | S, sale reported on Form 4 | 7,527 | $92.7K | 2026-06-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1201096) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms